Interestingly, patients with CAH and healthy controls were found to differ in the prevalence of at least 2 glucocorticoid receptor polymorphisms (BclI and Tth111I), which may suggest increased sensitivity of glucocorticoid substitution in patients with CAH (174, 175). Here, NR3C1 is linked to congenital adrenal hyperplasia.